Transition care for rare connective tissue diseases in Europe

🔹 67 responses from 59 centres, 20 countries
🔹 Only 40% have a standardised policy
🔹 29% transition based on age alone
🔹 Key barriers: lack of guidelines and provider training

Rheumatology Advances in Practice https://doi.org/10.1093/rap/rkae149